Sponsor Pipeline

WeiShi Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
2
Active Trials
2
Recruiting
Active Trials by Phase
Phase 4
1
Phase 2
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT07569653 Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT. Cytomegalovirus Infections Recruiting
Phase 2
NCT07606703 A Prospective Study of Madecassoside Tablets in Sclerotic Chronic Graft-versus-Host… Chronic Graft-Versus-Host Disease Recruiting
Get alerts when WeiShi's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free